Form 4: Verizon Executive Reports Phantom Stock Acquisition

Sentiment:

Insider Transaction Report


Verizon EVP Kyle Malady acquired phantom stock units equivalent to common stock, settled in cash upon specific events.

Summary

  • Kyle Malady, EVP and Group CEO of VZ Business at Verizon Communications Inc., acquired 129,025 phantom stock units on April 23, 2026.
  • These phantom stock units are economically equivalent to common stock but are settled in cash.
  • The phantom stock units become payable upon events established by the reporting person under a deferred compensation plan.
  • The acquisition was made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c) affirmative defense conditions.
  • Malady's beneficial ownership of common stock, including phantom stock, totals 410,898.178 shares, held indirectly through a deferred compensation plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports a routine insider transaction under a pre-arranged plan, providing no new information about the company's financial health or strategic direction.

Positives

  • Executive participation in equity-linked compensation plans, indicating alignment with company performance.
  • The transaction was conducted under a Rule 10b5-1(c) plan, suggesting pre-planned and potentially less market-impactful trading.
  • Acquisition of phantom stock units, which are tied to the economic performance of Verizon's common stock.

Negatives

  • The filing details a transaction by an executive, not a company-wide financial performance update, limiting broader positive interpretation.
  • Phantom stock is settled in cash, meaning no direct increase in common stock ownership by the executive.

Risks

  • The value of the phantom stock is subject to the future performance of Verizon's common stock.
  • The deferred compensation plan's terms and conditions could impact the timing and amount of cash settlement.
  • Potential for future sales of vested phantom stock (settled in cash) could impact market liquidity if aggregated with other transactions.

Future Outlook

The filing does not contain forward-looking statements or guidance. It solely reports a transaction by an executive.

Industry Context

StockSavvy.ai notes that insider transactions, particularly those under Rule 10b5-1 plans, are common in the telecommunications industry as a way for executives to manage their equity holdings in a structured manner. This filing reflects standard executive compensation practices within large-cap tech and telecom firms.

Comparison to Industry Standards

  • Many large telecommunications companies, including AT&T and T-Mobile, utilize phantom stock and deferred compensation plans as part of their executive compensation packages.
  • The use of Rule 10b5-1 trading plans is a widely adopted practice across the S&P 500 to provide executives with a pre-determined method for buying or selling company stock, mitigating concerns about insider trading.
  • The specific number of units acquired by Kyle Malady is a function of his compensation level and the company's equity valuation at the time of the grant or acquisition.

Stakeholder Impact

  • Shareholders: The transaction itself is unlikely to have a significant direct impact on the share price, as it is part of a pre-arranged plan and involves phantom stock settled in cash.
  • Employees: Reflects a standard component of executive compensation, potentially influencing morale and retention among senior leadership.
  • Management: Demonstrates the use of equity-linked incentives to retain and motivate key executives like Kyle Malady.

Next Steps

  • The phantom stock units will be settled in cash upon the occurrence of events established by the reporting person in accordance with the deferred compensation plan.

Key Dates

DateDescription
04/23/2026Earliest transaction date and date of phantom stock acquisition.
04/24/2026Date of signature for the filing.

Keywords

Verizon Communications, VZ, Form 4, Insider Trading, Executive Compensation, Phantom Stock, Deferred Compensation, Rule 10b5-1, Kyle Malady

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.